Kanagawa, Japan

Toru Takami

This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1984-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toru Takami. Retrieved from https://idiyas.com/inventor/toru-takami-wvy16h9e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1984-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Toru Takami

Introduction

Toru Takami is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aqueous solutions containing lipid-soluble substances. With a total of 2 patents, his work has garnered attention for its stability and ease of preparation.

Latest Patents

Toru Takami's latest patents include an aqueous solution containing a lipid-soluble pharmaceutical substance. This solution is characterized by a pH of 5.5-8 and includes hydrogenated lecithin and neutral amino acids. It is designed to be stable, free from side effects, and relatively easy to prepare. Another patent involves an aqueous solution containing ubidecarenone, which also incorporates hydrogenated lecithin, ensuring stability and the absence of side effects.

Career Highlights

Toru Takami is currently associated with Eisai Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective and safe solutions for various medical applications.

Collaborations

Throughout his career, Toru has collaborated with esteemed colleagues such as Noritoshi Koyama and Yoshio Kogure. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Toru Takami's contributions to the field of pharmaceuticals through his innovative patents highlight his expertise and commitment to improving medical solutions. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…